胸主动脉腔内修复术后30天再入院预测因素与资源利用
30天再入院率为17.4%,最常见原因为心脏(17.8%)、感染(16.0%)和肺部(12.1%);P=0.015),而医院年手术量未预测任何结局。
要点
- TEVAR术后30天再入院率为17.4%,心脏、感染和肺部原因最常见。
- 破裂性胸腹主动脉瘤是再入院最强预测因素(aOR 2.23,P=0.015)。
- 医院年TEVAR手术量未预测住院时长、费用或30天再入院。
核心结论
- 医院年TEVAR手术量与所评估的结局均无关,而TEVAR指征是许多结局的最强预测因素。
- 随着TEVAR应用增加,关注心脏和血管疾病可能减少再入院并改善医疗质量。
研究设计与样本
- 回顾性队列研究,使用美国全国再入院数据库2010至2014年数据。
- 采用多变量逻辑回归分析再入院的医院和患者层面因素。
主要发现
- 最常见指征为完整胸主动脉瘤(43.5%),其次为主动脉夹层(30.5%)。
- index住院平均费用为63 644±52 312美元,平均住院日11±14天,index死亡率为6.7%。
- 30天再入院率为17.4%,再入院原因以心脏(17.8%)、感染(16.0%)和肺部(12.1%)最常见。
- 医院手术量未预测index住院时长、费用或30天再入院(所有P>0.10)。
临床怎么用
- TEVAR术后应重点关注心脏和血管相关并发症,以降低再入院风险。
- 对破裂性胸腹主动脉瘤患者应加强术后随访和资源规划。
- 医院手术量不应作为预测TEVAR结局的独立依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The introduction and expansion of thoracic endovascular aortic repair (TEVAR) have revolutionized the treatment of a variety of thoracic aortic diseases. We sought to evaluate the incidence, causes, predictors and costs associated with 30-day readmission after TEVAR in a nationally representative cohort. METHODS: Adult patients undergoing isolated TEVAR were identified in the National Readmissions Database from 2010 to 2014. Hospital costs were estimated by converting individual hospital charge data adjusted to 2014 consumer price indices. Multivariable logistic regression was utilized to determine hospital- and patient-level factors associated with readmissions. RESULTS: A total of 24 983 TEVARs were noted during the study period; the average age of the patients was 65 ± 16 years; 40% were women. The most common indication was an intact thoracic aneurysm (43.5%), followed by aortic dissection (30.5%). The average cost of the index admission was $63 644 ± $52 312; the average hospital stay was 11 ± 14 days; the index mortality rate was 6.7%. Readmissions within 30 days occurred in 17.4% of patients. Indications for readmission were varied; the most common aetiologies were cardiac (17.8%), infectious (16.0%) and pulmonary (12.1%). On multivariable analysis, the strongest predictor of readmission was the diagnosis, with a ruptured thoraco-abdominal aneurysm having the highest readmission burden (adjusted odds ratio 2.23, 1.17-4.24; P = 0.015). Notably, hospital volume did not predict index hospital length of stay, costs or 30-day readmissions (all P > 0.10). CONCLUSIONS: Annual TEVAR volume was not associated with any of the outcomes assessed. Rather, indication for TEVAR was the strongest predictor for many outcomes. As TEVAR becomes increasingly utilized, a focus on cardiac and vascular diseases may reduce readmissions and improve quality of care.
引用
- Iyengar A, Goel NJ, Kelly JJ, et al. Predictors of 30-day readmission and resource utilization after thoracic endovascular aortic repair. Eur J Cardiothorac Surg. 2020. PMID: 32386207. doi:10.1093/ejcts/ezaa128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。